Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity
- PMID:134997
Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity
Abstract
A functionally active human plasmin light (B) chain derivative, stabilized by the streptomyces plasmin inhibitor leupeptin, was isolated from a partially reduced and alkylated enzyme preparation by an affinity chromatography method with a L-lysine-substituted Sepharose column. This light (B) chain derivative was found to be relatively homogeneous by electrophoretic analysis in both an acrylamide gel/dodecyl sulfate system and on cellulose acetate. It possessed approximately 3% of the proteolytic activity (casein substrate) of the original enzyme, and it incorporated 0.09 mol of [3H]diisopropyl phosphorofluoridate per mol of protein. It contained 3.1 +/- 0.3 carboxymethylated cysteines per mol of protein and can be designated as a CmCys5-light (B) chain (CmCys)3. When this isolated light (B) chain derivative was mixed in equal molar amounts with streptokinase, the mixture developed both human and bovine plasminogen activator activities; the bovine activator activity was approximately 66% of the bovine activator activity of the equimolar human plasmin-streptokinase complex. Although this complex now incorporated 0.50 mol of [3H]diisopropyl phosphorofluoridate per mol of protein, its proteolytic activity, on a molar basis, was the same as the proteolytic activity of the isolated light (B) chain derivative. It was shown by electrophoretic analysis in both an acrylamide gel/epsilon-aminocaproic acid system and on cellulose acetate that the light (B) chain derivative and streptokinase forms an equimolar light (B) chain-streptokinase complex, indicating that the binding site for streptokinase is located on the light (B) chain of the enzyme. A functionally active equimolar light (B) chain-streptokinase complex was also isolated from a partially reduced and alkylated equimolar human plasmin-streptokinase complex by the affinity chromatography method. The plasminogen activator activities (human and bovine) of this light (B) chain-streptokinase complex were similar to those of the plasmin-streptokinase complex from which it was derived. Although this complex incorporated 0.70 mol of [3H]diisopropyl phosphorofluoridate per mol of protein, its proteolytic activity, on a molar basis, was only 14% of proteolytic activity of the plasmin-streptokinase complex.
Similar articles
- Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.Wohl RC, Arzadon L, Summaria L, Robbins KC.Wohl RC, et al.J Biol Chem. 1977 Feb 25;252(4):1141-7.J Biol Chem. 1977.PMID:851483
- Activation of human and bovine plasminogens by the microplasmin and streptokinase complex.Shi GY, Change BI, Wu DH, Ha YM, Wu HL.Shi GY, et al.Thromb Res. 1990 May 1;58(3):317-29. doi: 10.1016/0049-3848(90)90101-h.Thromb Res. 1990.PMID:2141198
- The isolation and characterization of a ternary human plasmin B-chain-streptokinase-plasminogen complex.Summaria L, Boreisha I, Barlow GH, Robbins KC.Summaria L, et al.Thromb Haemost. 1987 Aug 4;58(2):772-7.Thromb Haemost. 1987.PMID:2960030
- Activation of human plasminogen by equimolar levels of streptokinase.Bajaj AP, Castellino FJ.Bajaj AP, et al.J Biol Chem. 1977 Jan 25;252(2):492-8.J Biol Chem. 1977.PMID:137901
- Species specificity of streptokinase.Marcum JA, Kline DL.Marcum JA, et al.Comp Biochem Physiol B. 1983;75(3):389-94. doi: 10.1016/0305-0491(83)90345-0.Comp Biochem Physiol B. 1983.PMID:6349918Review.
Cited by
- The human plasma fibrinolytic system: regulation and control.Robbins KC.Robbins KC.Mol Cell Biochem. 1978 Aug 16;20(3):149-57. doi: 10.1007/BF00243761.Mol Cell Biochem. 1978.PMID:151804Review.
- Structure and function of microplasminogen: II. Determinants of activation by urokinase and by the bacterial activator streptokinase.Wang J, Reich E.Wang J, et al.Protein Sci. 1995 Sep;4(9):1768-79. doi: 10.1002/pro.5560040912.Protein Sci. 1995.PMID:8528075Free PMC article.
- The domain organization of streptokinase: nuclear magnetic resonance, circular dichroism, and functional characterization of proteolytic fragments.Parrado J, Conejero-Lara F, Smith RA, Marshall JM, Ponting CP, Dobson CM.Parrado J, et al.Protein Sci. 1996 Apr;5(4):693-704. doi: 10.1002/pro.5560050414.Protein Sci. 1996.PMID:8845759Free PMC article.
- Preparation and purification of microplasmin.Wu HL, Shi GY, Bender ML.Wu HL, et al.Proc Natl Acad Sci U S A. 1987 Dec;84(23):8292-5. doi: 10.1073/pnas.84.23.8292.Proc Natl Acad Sci U S A. 1987.PMID:2960974Free PMC article.
- Analysis of the interactions between streptokinase domains and human plasminogen.Conejero-Lara F, Parrado J, Azuaga AI, Dobson CM, Ponting CP.Conejero-Lara F, et al.Protein Sci. 1998 Oct;7(10):2190-9. doi: 10.1002/pro.5560071017.Protein Sci. 1998.PMID:9792107Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources